Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 211Myeloid 152Sarcoma 104Gastrointestinal 88Lymphoid 51CNS 23Thoracic 19Dermatologic 16Genitourinary 15Other solid neoplasm 11Gynecologic 11Breast 10Tumor-Agnostic 9Head & Neck 7Plasma cell 4Endocrine 2Classical hematology 2Other neoplasm 1Other 1

Conditions

Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Imatinib Mesylate × Endocrine × Clear all
NCT03469011 2025-06-27

A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.

AHS Cancer Control Alberta

Phase 1 Terminated
14 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT00115739 2014-04-21

Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma

University of Michigan Rogel Cancer Center

Phase 2 Terminated
11 enrolled 10 charts
EndocrineHead & Neck

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡